Literature DB >> 9151875

Hepatitis B virus replication is cell cycle independent during liver regeneration in transgenic mice.

L G Guidotti1, B Matzke, F V Chisari.   

Abstract

The content of hepatitis B virus (HBV) replicative forms and HBV core protein in the liver of HBV transgenic mice is transiently reduced during massive liver regeneration following partial hepatectomy while the steady-state content of viral RNA is unchanged. This antiviral effect is triggered by interferon and tumor necrosis factor that are induced in the liver following hepatectomy and either prevent the formation or accelerate the degradation of viral nucleocapsids in the cytoplasm of the hepatocyte. Despite massive hepatocellular turnover, this effect is independent of liver cell division, indicating that HBV replicates efficiently in resting and dividing hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151875      PMCID: PMC191703     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.

Authors:  R D Schreiber; L J Hicks; A Celada; N A Buchmeier; P W Gray
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

2.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.

Authors:  L G Guidotti; T Ishikawa; M V Hobbs; B Matzke; R Schreiber; F V Chisari
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

Review 3.  Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration.

Authors:  N Fausto; A D Laird; E M Webber
Journal:  FASEB J       Date:  1995-12       Impact factor: 5.191

4.  Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice.

Authors:  S N Huang; F V Chisari
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

5.  Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.

Authors:  I Fourel; J M Cullen; J Saputelli; C E Aldrich; P Schaffer; D R Averett; J Pugh; W S Mason
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver.

Authors:  L G Guidotti; P Borrow; M V Hobbs; B Matzke; I Gresser; M B Oldstone; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Acute viral hepatitis: morphologic and functional correlations in human livers.

Authors:  T Uchida; I Kronborg; R L Peters
Journal:  Hum Pathol       Date:  1984-03       Impact factor: 3.466

8.  High-level hepatitis B virus replication in transgenic mice.

Authors:  L G Guidotti; B Matzke; H Schaller; F V Chisari
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes.

Authors:  L V Tsui; L G Guidotti; T Ishikawa; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.

Authors:  I Gresser; M G Tovey; M E Bandu; C Maury; D Brouty-Boyé
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  14 in total

1.  Autophagy required for hepatitis B virus replication in transgenic mice.

Authors:  Yongjun Tian; Donna Sir; Cheng-Fu Kuo; David K Ann; Jing-Hsiung James Ou
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

Review 2.  Cell cycle regulation during viral infection.

Authors:  Sumedha Bagga; Michael J Bouchard
Journal:  Methods Mol Biol       Date:  2014

3.  Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes.

Authors:  U Schultz; J Summers; P Staeheli; F V Chisari
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.

Authors:  Yuchen Xia; Xiaoming Cheng; Yao Li; Kristin Valdez; Weiping Chen; T Jake Liang
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

5.  Viral-load-dependent effects of liver injury and regeneration on hepatitis B virus replication in mice.

Authors:  Yongjun Tian; Wen-ling Chen; Cheng-fu Kuo; Jing-hsiung James Ou
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

6.  Inhibition of hepatitis B virus by oxymatrine in vivo.

Authors:  X S Chen; G J Wang; X Cai; H Y Yu; Y P Hu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

7.  Immune effectors required for hepatitis B virus clearance.

Authors:  Priscilla L Yang; Alana Althage; Josan Chung; Holly Maier; Stefan Wieland; Masanori Isogawa; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

8.  The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication.

Authors:  Tricia L Gearhart; Michael J Bouchard
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

9.  Hepatitis B Virus Polymerase Localizes to the Mitochondria, and Its Terminal Protein Domain Contains the Mitochondrial Targeting Signal.

Authors:  Nuruddin Unchwaniwala; Nathan M Sherer; Daniel D Loeb
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  Differential inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by the small heterodimer partner.

Authors:  Claudia E Oropeza; Lie Li; Alan McLachlan
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.